動物用ワクチンの世界市場:産業分析、市場規模、市場シェア、成長、動向、予測

◆英語タイトル:Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024
◆商品コード:TMR60922
◆発行会社(調査会社):Transparency Market Research
◆発行日:2016年8月19日
◆ページ数:185
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥643,245見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥976,245見積依頼/購入/質問フォーム
Corporate LicenseUSD11,795 ⇒換算¥1,309,245見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、動物用ワクチンの世界市場について調査・分析し、産業分析、動物用ワクチンの世界市場規模、市場シェア、成長、市場動向、予測データを含め、以下の構成でお届けいたします。
・動物用ワクチンの世界市場:序文
・動物用ワクチンの世界市場:エグゼクティブサマリー
・動物用ワクチンの世界市場:市場概要・動向
・動物用ワクチンの世界市場:セグメント別市場規模・分析
・動物用ワクチンの世界市場:地域別市場規模・分析
・動物用ワクチンの世界市場:関連企業分析
【レポートの概要】

Veterinary vaccines are extensively used in the prevention of life-threatening animal diseases. This report on the global veterinary vaccines market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, which includes a market snapshot providing overall information on various segments and sub-segments. This section also provides complete information and data analysis of the global veterinary vaccines market with respect to the leading market segments based on technology type, animal type, and geography.
The report is a combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via email. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various national and international databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro-environmental factors. Growth rates for each segment within the global veterinary vaccines market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, vaccination expenditure, and regulatory requirements.
Increase in prevalence of animal diseases, surge in investments by government bodies, rise in demand for milk, meat, eggs, and fish; high expenditure on companion animals, and growing awareness about vaccination among the middle class are the major factors that propel demand for veterinary vaccines. Stringent market regulations and high R&D cost are the major factors likely to hamper the veterinary vaccines market.
The market overview section of the report includes qualitative analysis of the overall veterinary vaccines market including the determining factors and market dynamics such as drivers, restraints, and opportunities, along with white space analysis. In addition, market attractiveness analysis by geography, animal type, and technology type, and competitive landscape by key players have been provided which explain the intensity of competition in the market considering different geographies. The competitive scenario between market players has been evaluated through market share analysis. These factors would help the market players take strategic decisions in order to strengthen their positions and increase their shares in the global market.
The global veterinary vaccines market has been segmented based on technology type, animal type, and geography. Based on technology type, the market has been categorized into inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, and other vaccines such as recombinant vaccines, DNA vaccines, and subunit vaccines. Companion vaccines and livestock vaccines are the major segments by animal type. The companion vaccines segment comprises canine vaccines, feline vaccines, and equine vaccines. The livestock vaccines segment includes porcine, poultry, bovine, ovine, and other vaccines. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 has been provided for all the segments, considering 2015 as the base year.
Geographically, the veterinary vaccines market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The mentioned regions are further analyzed by major countries contributing to the market. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the veterinary vaccines market. The report also profiles major players based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players in the global veterinary vaccines market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim GmbH, Ceva Santé Animale, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi S.A. (Merial Animal Health), Virbac, and Zoetis, Inc.
The global veterinary vaccines market has been segmented as follows:
Global Veterinary Vaccines Market, by Animal Type
• Animal Type
o Companion Animals
 Equine
 Canine
 Feline
o Livestock Animals
 Bovine
 Ovine
 Porcine
 Poultry
 Others
Global Veterinary Vaccines Market, by Technology Type
• Inactivated Vaccines
• Live Attenuated Vaccines
• Conjugate Vaccines
• Toxoid Vaccines
• Other Vaccines
Global Veterinary Vaccines Market, by Geography
• North America
o U.S.
o Canada
• Europe
o U.K.
o Germany
• Asia Pacific
o China
o Japan
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
• Middle East & Africa
o Saudi Arabia
o Rest of MEA

【レポートの目次】

Chapter 1 Preface
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Key Questions Answered

Chapter 2 Assumptions and Research Methodology
2.1 Report Assumptions
2.2 Acronyms Used
2.3 Research Methodology

Chapter 3 Executive Summary
3.1 Global Veterinary Vaccines Market Snapshot
3.2 Market Opportunity Map

Chapter 4 Market Overview
4.1 Product Overview
4.2 Key Industry Events
4.3 Disease Outbreak Globally: Livestock Animals Disease
4.4 Main (Vector Borne Disease) VBDs affecting livestock
4.5 List of countries representing each virus pool (FMD) for the period 2010–2014
4.6 Animal Population (Mn), by Country in 2015
4.7 Regulatory Scenario

Chapter 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 White Space Analysis

Chapter 6 Veterinary Vaccines Market Analysis, by Technology Type, (US$ Mn) 2014–2024
6.1 Key Findings
6.2 Introduction
6.3 Inactivated Vaccines
6.4 Live Attenuated Vaccines
6.5 Conjugate Vaccines
6.6 Toxoid Vaccines
6.7 Recombinant Vaccines
6.8 DNA Vaccines
6.9 Key Trends
6.10 Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, 2015

Chapter 7 Veterinary Vaccines Market Analysis, by Animal Type, (US$ Mn), 2014–2024
7.1 Key Findings
7.2 Introduction
7.3 Veterinary vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
7.3.1 Equine
7.3.2 Canine
7.3.3 Feline
7.4 Veterinary vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
7.4.1 Bovine
7.4.2 Ovine
7.4.3 Porcine
7.4.4 Poultry
7.5 Key Trends
7.6 Veterinary Vaccines Market Attractiveness Analysis, by Animal Type

Chapter 8 Veterinary Vaccines Market Analysis, by Region, (US$ Mn), 2014–2024
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Latin America
8.5 Middle East & Africa
8.6 Geographical Scenario
8.7 Veterinary Vaccines Market Attractiveness Analysis, by Region, 2015

Chapter 9 North America Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
9.1 North America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
9.1.1 Inactivated Vaccines
9.1.2 Conjugate Vaccines
9.1.3 Live Attenuated Vaccines
9.1.4 Toxoid Vaccines
9.1.5 Other Vaccines
9.2 North America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
9.2.1 Animal Type
9.2.1.1 Companion Animals
9.2.1.1.1 Equine
9.2.1.1.2 Canine
9.2.1.1.3 Feline
9.2.1.2 Livestock Animals
9.2.1.2.1 Bovine
9.2.1.2.2 Ovine
9.2.1.2.3 Porcine
9.2.1.2.4 Poultry
9.2.1.2.5 Others
9.3 U.S. Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
9.4 Canada Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 10 Europe Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
10.1 Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
10.1.1 Inactivated Vaccines
10.1.2 Conjugate Vaccines
10.1.3 Live Attenuated Vaccines
10.1.4 Toxoid Vaccines
10.1.5 Other Vaccines
10.2 Europe Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
10.2.1 Animal Type
10.2.1.1 Companion Animals
10.2.1.1.1 Equine
10.2.1.1.2 Canine
10.2.1.1.3 Feline
10.2.1.2 Livestock Animals
10.2.1.2.1 Bovine
10.2.1.2.2 Ovine
10.2.1.2.3 Porcine
10.2.1.2.4 Poultry
10.2.1.2.5 Others
10.3 Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
10.4 Germany Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
10.5 U.K. Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 11 Asia Pacific Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
11.1 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
11.1.1 Inactivated Vaccines
11.1.2 Conjugate Vaccines
11.1.3 Live Attenuated Vaccines
11.1.4 Toxoid Vaccines
11.1.5 Other Vaccines
11.2 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
11.2.1 Animal Type
11.2.1.1 Companion Animals
11.2.1.1.1 Equine
11.2.1.1.2 Canine
11.2.1.1.3 Feline
11.2.1.2 Livestock Animals
11.2.1.2.1 Bovine
11.2.1.2.2 Ovine
11.2.1.2.3 Porcine
11.2.1.2.4 Poultry
11.2.1.2.5 Others
11.3 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
11.4 China Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
11.5 Japan Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 12 Latin America Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
12.1 Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
12.1.1 Inactivated Vaccines
12.1.2 Conjugate Vaccines
12.1.3 Live Attenuated Vaccines
12.1.4 Toxoid Vaccines
12.1.5 Other Vaccines
12.2 Latin America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
12.2.1 Animal Type
12.2.1.1 Companion Animals
12.2.1.1.1 Equine
12.2.1.1.2 Canine
12.2.1.1.3 Feline
12.2.1.2 Livestock Animals
12.2.1.2.1 Bovine
12.2.1.2.2 Ovine
12.2.1.2.3 Porcine
12.2.1.2.4 Poultry
12.2.1.2.5 Others
12.3 Latin America Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
12.4 Brazil Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
12.5 Mexico Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 13 Middle East & Africa Veterinary Vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
13.1 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
13.1.1 Inactivated Vaccines
13.1.2 Conjugate Vaccines
13.1.3 Live Attenuated Vaccines
13.1.4 Toxoid Vaccines
13.1.5 Other Vaccines
13.2 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
13.2.1 Animal Type
13.2.1.1 Companion Animals
13.2.1.1.1 Equine
13.2.1.1.2 Canine
13.2.1.1.3 Feline
13.2.1.2 Livestock Animals
13.2.1.2.1 Bovine
13.2.1.2.2 Ovine
13.2.1.2.3 Porcine
13.2.1.2.4 Poultry
13.2.1.2.5 Others
13.3 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
13.4 Saudi Arabia Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024

Chapter 14 Competitive Landscape
14.1 Veterinary Vaccine Market Share Analysis, by Company, (2015)
14.2 Competition Matrix
14.2.1 Bayer AG
14.2.2 Bimeda, Inc.
14.2.3 Boehringer Ingelheim GmbH
14.2.4 Ceva Santé Animale
14.2.5 Eli Lilly and Company (Elanco Animal Health)
14.2.6 Merck Animal Health
14.2.7 Sanofi S.A. (Merial Animal Health)
14.2.8 Virbac
14.2.9 Zoetis, Inc.
14.3 Company Profiles
14.3.1 Bayer AG
14.3.1.1 Company Details
14.3.1.2 Company Description
14.3.1.3 Business Overview
14.3.1.4 SWOT Analysis
14.3.1.5 Financials
14.3.1.6 Strategic Overview
14.3.1.7 Product Portfolio
14.3.1.8 Recent Developments
14.3.2 Bimeda, Inc.
14.3.2.1 Company Details
14.3.2.2 Company Description
14.3.2.3 Business Overview
14.3.2.4 SWOT Analysis
14.3.2.5 Financials
14.3.2.6 Strategic Overview
14.3.2.7 Product Portfolio
14.3.2.8 Recent Developments
14.3.3 Boehringer Ingelheim GmbH
14.3.3.1 Company Details
14.3.3.2 Company Description
14.3.3.3 Business Overview
14.3.3.4 SWOT Analysis
14.3.3.5 Financials
14.3.3.6 Strategic Overview
14.3.3.7 Product Portfolio
14.3.3.8 Recent Developments
14.3.4 Ceva Santé Animale
14.3.4.1 Company Details
14.3.4.2 Company Description
14.3.4.3 Business Overview
14.3.4.4 SWOT Analysis
14.3.4.5 Financials
14.3.4.6 Strategic Overview
14.3.4.7 Product Portfolio
14.3.4.8 Recent Developments
14.3.5 Eli Lilly and Company (Elanco Animal Health)
14.3.5.1 Company Details
14.3.5.2 Company Description
14.3.5.3 Business Overview
14.3.5.4 SWOT Analysis
14.3.5.5 Financials
14.3.5.6 Strategic Overview
14.3.5.7 Product Portfolio
14.3.5.8 Recent Developments
14.3.6 Merck Animal Health
14.3.6.1 Company Details
14.3.6.2 Company Description
14.3.6.3 Business Overview
14.3.6.4 SWOT Analysis
14.3.6.5 Financials
14.3.6.6 Strategic Overview
14.3.6.7 Product Portfolio
14.3.6.8 Recent Developments
14.3.7 Sanofi S.A. (Merial Animal Health)
14.3.7.1 Company Details
14.3.7.2 Company Description
14.3.7.3 Business Overview
14.3.7.4 SWOT Analysis
14.3.7.5 Financials
14.3.7.6 Strategic Overview
14.3.7.7 Product Portfolio
14.3.7.8 Recent Developments
14.3.8 Virbac
14.3.8.1 Company Details
14.3.8.2 Company Description
14.3.8.3 Business Overview
14.3.8.4 SWOT Analysis
14.3.8.5 Financials
14.3.8.6 Strategic Overview
14.3.8.7 Product Portfolio
14.3.8.8 Recent Developments
14.3.9 Zoetis, Inc.
14.3.9.1 Company Details
14.3.9.2 Company Description
14.3.9.3 Business Overview
14.3.9.4 SWOT Analysis
14.3.9.5 Financials
14.3.9.6 Strategic Overview
14.3.9.7 Product Portfolio
14.3.9.8 Recent Developments

List of Figures

FIG. 1 Global Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 2 Global Inactivated Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 3 Global Live Attenuated Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 4 Global Conjugate Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 5 Global Toxoid Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 6 Global Recombinant Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 7 Global DNA Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 8 Global Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 9 Global Equine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 10 Global Canine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 11 Global Feline Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 12 Global Companion Animal Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 13 Global Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 14 Global Bovine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 15 Global Ovine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 16 Global Porcine Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 17 Global Poultry Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 18 Global Veterinary Vaccines Market Value Share Analysis, by Region, 2015 and 2024
FIG. 19 Veterinary Vaccines Market Attractiveness Analysis, by Region, (US$ Mn), 2014–2024
FIG. 20 Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, (US$ Mn), 2014–2024
FIG. 21 Veterinary Vaccines Market Attractiveness Analysis, by Animal Type, (US$ Mn), 2014–2024
FIG. 22 North America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 23 North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 24 North America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 25 North America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 26 U.S. Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 27 Canada Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 28 Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 29 Europe Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 30 Europe Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 31 Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
FIG. 32 Germany Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 33 U.K. Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 34 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 35 Asia Pacific Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 36 Asia Pacific Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 37 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn) 2015 and 2024
FIG. 38 China Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 39 Japan Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 40 Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 41 Latin America Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 42 Latin America Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 43 Latin America Market Value Share Analysis, by Country, (US$ Mn), 2015 and 2024
FIG. 44 Brazil Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 45 Mexico Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 46 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2015 and 2024
FIG. 47 Middle East & Africa Veterinary Vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 48 Middle East & Africa Veterinary Vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2015 and 2024
FIG. 49 Saudi Arabia Veterinary Vaccines Market Revenue, (US$ Mn), 2014–2024
FIG. 50 Global Veterinary Vaccines Market Share Analysis, by Company (%) (2015)

List of Tables

Table 1. Global Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 2. Global Veterinary Vaccines (companion animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 3. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 4. Global Veterinary Vaccines Market Size Forecast, by Region, (US$ Mn), 2014–2024
Table 5. North America Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 6. Global Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 7. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 8. North America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 9. Europe Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 10. Europe Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 11. Europe Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 12. Europe Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 13. Asia Pacific Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 14. Asia Pacific Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 15. Asia Pacific Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 16. Asia Pacific Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 17. Latin America Veterinary Vaccines Market Size (US$ Mn) Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 18. Latin America Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 19. Latin America Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 20. Latin America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 21. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 22. Middle East & Africa Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 23. Middle East & Africa Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 24. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024



【レポートのキーワード】

動物用ワクチン、不活性ワクチン、弱毒化生ワクチン、共役ワクチン、組み換えワクチン

★調査レポート[動物用ワクチンの世界市場:産業分析、市場規模、市場シェア、成長、動向、予測]販売に関する免責事項
★調査レポート[動物用ワクチンの世界市場:産業分析、市場規模、市場シェア、成長、動向、予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆